在固体瘤中TET2的作用及其治疗潜力:综合性综述
Wenxin Da1, Ziyu Song1, Xiaodong Liu1
1Department of Immunology, Jiangsu Key Laboratory of Laboratory Medicine, Department of Laboratory Medicine, School of Medicine, Jiangsu University, Xuefu Road No. 301, Zhenjiang, 212013, China.
概括
通过十-十一转位2 (TET2) 调节的DNA甲基化影响瘤的发展. 本研究探讨了TET2的情况.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 瘤是一个重大的全球健康挑战,需要对其发展机制有深入的了解.
- 表观遗传学,特别是DNA甲基化,显著影响基因表达,并在瘤发生过程中发挥关键作用.
- 十-十一转位2 (TET2) 是DNA甲基化修饰中的关键蛋白质,主要以其在血液性恶性瘤中的瘤抑制功能而闻名.
研究的目的:
- 研究十一转位2 (TET2) 在固体瘤中的作用和调控机制.
- 为了突出TET2在固体瘤发育中的低估参与,与其在血液病中的已知作用相比.
- 探索TET2作为恶性固体瘤新型向治疗的临床点的潜力.
主要方法:
- 对与TET2.2相关的DNA甲基化模式的分析.
- 在固体瘤发育的背景下,研究TET2的调节功能.
- 对血液病中TET2的现有文献的审查及其对固体瘤的潜在影响.
主要成果:
- DNA甲基化是瘤发育中的关键表观遗传机制,TET2发挥着重要的调节作用.
- 虽然TET2在血液学疾病中的功能已经得到了充分的证据,但它在固体瘤中的作用在很大程度上仍未被探索.
- 了解固体瘤中TET2的机制对于推进癌症研究和治疗策略至关重要.
结论:
- 表观遗传修饰,包括由TET2调节的DNA甲基化,对于瘤发育至关重要.
- 对TET2在固体瘤中的功能进行进一步的研究是有必要的,以揭示其作为治疗点的潜力.
- 在固体瘤中研究TET2可能为恶性瘤的新临床治疗铺平道路.
相关概念视频
01:27Tumor Immunotherapy
522
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
522
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:38Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K